A First-in-Human Phase I Study of the ATP-Competitive Akt Inhibitor Ipatasertib (GDC-0068) Demonstrates Robust and Safe Targeting of Akt in Patients with Solid Tumors
Saura, C., Roda, D., Rosello, S., Oliveira, M., Macarulla, T., Perez-Fidalgo, J. A., Morales-Barrera, R., Sanchis-Garcia, J. M., Musib, L., Budha, N., Zhu, J., Nannini, M., Chan, W. Y., Sanabria BohorJournal:
Cancer Discovery
DOI:
10.1158/2159-8290.CD-16-0512
Date:
November, 2016
File:
PDF, 1.68 MB
2016
File converter
More search results
More benefits 
